Markets already have a rough guide on what to expect, with the London-based firm revealing back in January that it expects full year revenue to come in at around £102mln, 73% higher than what it reported a year earlier.
The company didn’t guide on profits, but Whitman Howard analyst Chris Wickham expects them to come in ahead of expectations, while Shore Capital analyst Phil Carroll is forecasting a pre-tax profit of £36mln.
The consensus is for diluted earnings per share (EPS) to continue its positive momentum and come in at around 24p, although Wickham is predicting 25.2p.
Given Fevertree’s premium valuation, investors will be keeping a close eye on sales so far in 2017, with continued growth vital to underpin the share price.
Upgrades tend to follow Fevertree announcements, and should overall sales growth show no real sign of slowing, this one could follow a similar theme.
The one slight negative in January’s update was that there seemed to be a half-on-half slowdown in growth in continental Europe and in the USA; two big, as yet unrealised opportunities for the company.
Keep an eye on how things have fared in these markets so far in 2017.
There should also be an update on the company’s new mixers. To try and tap the huge American market (where they prefer dark spirits to, say, gin), Fevertree has been working on new ginger beer products so it’ll be interesting to hear how these are coming along.
Tuesday 21 March
Interims: Bellway PLC (LON:BWY), Earthport plc (LON:EPO). Finals: Judges Scientific PLC (LON:JDG), Nahl Group (LON:NAH, Smart Metering Systems (LON:SMS, IQE plc (LON:IQE),Hansteen Holdings plc (LON:HSTN, Augean PLC (LON:AUG), Amec Foster Wheeler PLC (LON:AMFW),888 Holdings PLC (LON:888),EKF Diagnostics Holdings PLC (LON:EKF),EnQuest Plc (LON:ENQ), Ubisense Group PLC (LON:UBI), Vectura Group PLC (LON:VEC), Fevertree Drinks Plc (LON:FEVR),Safecharge International Group (LON:SCH)